StatSure Diagnostic Systems, Inc.
Other OTCTotal Valuation
StatSure Diagnostic Systems, Inc. carries a market capitalization of 107,057.00, placing it among publicly traded companies globally. Its enterprise value stands at 5.26M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 107,057.00 |
| Enterprise Value | 5.26M |
Share Statistics
StatSure Diagnostic Systems, Inc. currently has 3.97M shares outstanding.
| Shares Outstanding | 3.97M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
StatSure Diagnostic Systems, Inc. trades at a trailing price-to-earnings ratio of 14.26. The price-to-sales ratio is 1.17, and the price-to-book ratio stands at -0.08.
| PE Ratio | 14.26 |
| PS Ratio | 1.17 |
| PB Ratio | -0.08 |
| P/TBV Ratio | -1.45 |
| P/FCF Ratio | -889.87 |
| P/OCF Ratio | -115.96 |
Enterprise Valuation
The EV/Sales ratio of 1.57 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 3.20 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.57 |
| EV / EBITDA | 3.13 |
| EV / EBIT | 3.20 |
| EV / FCF | N/A |
Financial Position
StatSure Diagnostic Systems, Inc. maintains a current ratio of 0.06, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.06 |
| Quick Ratio | 0.06 |
| Debt / Equity | -57.63 |
| Debt / EBITDA | 0.89 |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | 103.52 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 9.78 |
Income Statement
Over the trailing twelve months, StatSure Diagnostic Systems, Inc. generated 3.34M in revenue and converted that into 393,465.00 in net income, yielding earnings per share of 0.09. EBITDA reached 1.68M, while operating income came in at 1.65M.
| Revenue | 3.34M |
| Gross Profit | 3.11M |
| Operating Income | 1.65M |
| Pretax Income | 980,558.00 |
| Net Income | 393,465.00 |
| EBITDA | 1.68M |
| EBIT | 1.65M |
| Earnings Per Share (EPS) | 0.09 |
Balance Sheet
StatSure Diagnostic Systems, Inc. holds 152,757.00 in cash and equivalents against 1.50M in total debt, resulting in a net debt position of 1.34M. Total book value stands at -50.39M, with working capital of -2.60M providing operational flexibility.
| Cash & Cash Equivalents | 152,757.00 |
| Total Debt | 1.50M |
| Net Debt | 1.34M |
| Equity (Book Value) | -50.39M |
| Book Value Per Share | -12.87 |
| Working Capital | -2.60M |
Cash Flow
StatSure Diagnostic Systems, Inc. produced -33,774.00 in operating cash flow over the past twelve months. After subtracting -29,051.00 in capital expenditures, free cash flow totaled -62,825.00 - equivalent to -0.02 per share.
| Operating Cash Flow | -33,774.00 |
| Capital Expenditures | -29,051.00 |
| Free Cash Flow | -62,825.00 |
| FCF Per Share | -0.02 |
Margins
StatSure Diagnostic Systems, Inc. operates with a gross margin of 92.95, reflecting its pricing power and cost economics. The operating margin of 49.22 and net profit margin of 11.77 provide insight into operational efficiency.
| Gross Margin | 92.95 |
| Operating Margin | 49.22 |
| Pretax Margin | 29.34 |
| Profit Margin | 11.77 |
| EBITDA Margin | 50.33 |
Dividends & Yields
The company's payout ratio of -43.25 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | -43.25 |
| Shareholder Yield | -1.40 |
| FCF Yield | -0.11 |
Stock Splits
StatSure Diagnostic Systems, Inc.'s most recent stock split took place on July 14, 2011 with a 10:1 split ratio.
| Last Split Date | 7/14/2011 |
| Split Ratio | 10:1 |
Scores
StatSure Diagnostic Systems, Inc. posts an Altman Z-Score of -308.90, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -308.90 |